Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas
2004 ◽
Vol 3
(1)
◽
pp. 102
2020 ◽
2020 ◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 2
(1_suppl)
◽
pp. s-0032-1319994-s-0032-1319994
Keyword(s):
Keyword(s):